Obesity, a worldwide epidemic, confers increased risk for multiple serious conditions,
including type 2 diabetes, cardiovascular diseases, nonalcoholic fatty liver disease and …

Obesity, which is a worldwide epidemic, confers increased risk for multiple serious
conditions including type 2 diabetes, nonalcoholic fatty liver disease, and cardiovascular …

Interactions between macrophages and adipocytes influence both metabolism and
inflammation. Obesity-induced changes to macrophages and adipocytes lead to chronic …

Abstract The NLRP3-IL-1β pathway plays an important role in adipose tissue (AT)-induced
inflammation and the development of obesity-associated comorbidities. We aimed to …

Objective Efforts to manage non-alcoholic fatty liver disease (NAFLD) are limited by the
incomplete understanding of the pathogenic mechanisms and the absence of accurate non …

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its severe subgroup
metabolic dysfunction-associated steatohepatitis (MASH) have become a global epidemic …

IL-32 is a multifaceted cytokine associated with several diseases and inflammatory
conditions. Its expression is induced in response to cellular stress such as hypoxia …

Fatty liver disease can be triggered by a combination of excess alcohol, dysmetabolism and
other environmental cues, which can lead to steatohepatitis and can evolve to acute/chronic …

A sedentary lifestyle is associated with overweight/obesity, which involves excessive fat
body accumulation, triggering structural and functional changes in tissues, organs, and body …

Background Previous studies have documented that visceral adipose tissue is positively
associated with the risk of diabetes. However, the association of subcutaneous adipose …